The American Cancer Society helps men with prostate cancer in every community. And we’re funding research to help find more cures and save even more lives in the future.
Studies show that Black men are 2 times more likely to die from prostate cancer than White men are. A main cause could be disparities in the assessibility and delivery of quality care.
Evidence keeps building that Black men are less likely to receive high-quality care for prostate cancer. When treatment is similar, prostate cancer 10-year survival is comparable or even higher among Black men.
It is yet to be seen whether the 2018 updated USPSTF recommendations for informed decision-making for PSA-based screening for men ages 55 to 69 years will lead to an increase in PSA testing and halt or reverse the rise in late-stage prostate cancer-incidence rates.”
The ACS funds scientists who conduct research about prostate cancer at medical schools, universities, research institutes, and hospitals throughout the United States. We use a rigorous and independent peer review process to select the most innovative research project proposals to fund.
Stats below are as of July 15, 2024.
If this was helpful, donate to help fund patient support services, research, and cancer content updates.